MH:NYSEMcGraw Hill, Inc. Analysis
Data as of 2026-08-18 - not real-time
$13.01
Latest Price
8/10Risk
Risk Level: High
Executive Summary
At $13.01, McGraw Hill, Inc. shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has gained 23.9%. With RSI at 68.5 the momentum picture is approaching overbought, alongside a bullish MACD signal. Watch $8.97 as support and $13.67 as the nearer resistance level.
On valuation the read is fair — an earnings multiple of 26.5, absent a reliable peer benchmark. The average analyst target implies 37.1% above today's level. Revenue is growing at 2.6% on a 4.4% profit margin.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 67.4%, a beta of 0.20 and a maximum drawdown of 49.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
On valuation the read is fair — an earnings multiple of 26.5, absent a reliable peer benchmark. The average analyst target implies 37.1% above today's level. Revenue is growing at 2.6% on a 4.4% profit margin.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 67.4%, a beta of 0.20 and a maximum drawdown of 49.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Top Market Events
McGraw Hill, Inc. NYSE:MH shares gained 3.9% after the education solutions provider delivered first-quarter earnings...COLUMBUS, Ohio, July 28, 2026--McGraw Hill, Inc.McGraw Hill, Inc. NYSE:MH was among the stocks Jim Cramer discussed as he said that the Iran peace negotiations could...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 13.21
- MACD momentum is positive
- 30-day price change of +23.9%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 13.21
- Analyst targets imply +37.1% versus the current price
- 30-day volatility of 67.4%
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Analyst targets imply +37.1% versus the current price
- P/E ratio of 26.5
- Return on equity of 17.3%
Key Metrics & Analysis
Financial Health
Revenue Growth2.60%
Profit Margin4.38%
P/E Ratio26.5
ROE17.30%
ROA3.90%
Debt/Equity336.61
P/B Ratio3.2
Op. Cash Flow$428.4M
Free Cash Flow$435.6M
Technical Analysis
TrendNeutral
RSI68.5
Support$8.97
Resistance$13.67
MA 20$11.13
MA 50$10.72
MA 200$13.21
MACDBullish
VolumeIncreasing
Fear & Greed Index93.14
Valuation
Fair Value$19.79
Target Price$17.83
Upside/Downside37.10%
GradeFair
TypeBlend
Risk Assessment
Beta0.20
Volatility67.42%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.